Form 4: Core Scientific EVP, CFO James P. Nygaard Jr. Reports Acquisition of 819,672 Shares of Common Stock

Sentiment:

SEC Form 4 Filing


James P. Nygaard Jr., EVP and CFO of Core Scientific, Inc., reports acquiring 819,672 shares of common stock through a restricted stock unit grant.

Summary

  • On March 26, 2025, James P. Nygaard Jr., the EVP and Chief Financial Officer of Core Scientific, Inc., acquired 819,672 shares of common stock.
  • This acquisition was a result of a restricted stock unit (RSU) grant.
  • The RSUs will vest in equal installments over three years, starting on the first anniversary of March 17, 2025, contingent upon continued service to the Issuer.
  • Following the reported transaction, Nygaard directly owns 1,017,762 shares of Core Scientific, Inc.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a standard executive compensation practice that aligns management interests with shareholders, indicating confidence in the company's future.

Positives

  • The RSU grant aligns the executive's interests with the long-term performance of the company.
  • The vesting schedule incentivizes continued service and commitment from the CFO.

Future Outlook

The document does not contain specific forward-looking statements, but the RSU grant suggests an expectation of continued service from the CFO.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency to investors regarding the alignment of management's interests with shareholders'.

Stakeholder Impact

  • Shareholders may view the RSU grant as a positive sign, aligning executive compensation with company performance.
  • Employees may see this as a standard practice for executive compensation.

Key Dates

DateDescription
03/17/2025Date from which the RSU vesting schedule is calculated.
03/26/2025Date of the transaction (acquisition of shares).
03/27/2025Date of signature on the Form 4 filing.

Keywords

Core Scientific, James P. Nygaard Jr., CFO, EVP, Form 4, Beneficial Ownership, Restricted Stock Units, RSU, CORZ, Stock Acquisition, Vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.